Skip to content
Sign In Subscribe
Supplier News

Watson, Akorn release generic Vancocin

Watson Pharmaceuticals Inc. and Akorn Inc. have shipped vancomycin hydrochloride capsules, an antibiotic used to treat infections of the intestines that cause colitis. The companies said Tuesday that their products, offered in strengths of 125 mg and 250 mg, are generic versions of ViroPharma Inc.

,   and  Chain Drug Review
1 min read

Table of Contents

NEW YORK — Watson Pharmaceuticals Inc. and Akorn Inc. have shipped vancomycin hydrochloride capsules, an antibiotic used to treat infections of the intestines that cause colitis.

The companies said Tuesday that their products, offered in strengths of 125 mg and 250 mg, are generic versions of ViroPharma Inc.’s Vancocin.

According to Watson and Acorn, Vancocin is indicated for the treatment of Clostridium difficile-associated diarrhea (CDAD) and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.

Vancocin capsules had U.S. sales of $332 million for the 12 months ended Feb. 29, according to IMS Health figures cited by Watson.

Comments

Related

Latest

FMI: Private brands take hold
Retail News

FMI: Private brands take hold

Perceptions around private brands have changed; they are no longer seen merely as generics or national brand equivalents, Doug Baker, vice president, industry relations at FMI, said in releasing the report, titled “The Power of Private Brands 2024.”

,   and  Chain Drug Review